Grading Average = 91. Errata Michaelis-Menten Derivation KmKm k cat Formation of ES complex is rapid (k cat <<k off ), therefore Rate Limiting.

Slides:



Advertisements
Similar presentations
First, zero, pseudo-zero order elimination Clearance
Advertisements

Pages 645 to 724 Mechanisms of Drug Interaction Pharmacokinetic –Reduced rate and/or completeness of absorption –Altered bioavailabilty –Reduced.
HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Enzymes. What is an enzyme? globular protein which functions as a biological catalyst, speeding up reaction rate by lowering activation energy without.
Pharmacokinetics -- part 1 --
Pharmacokinetics Questions
Nonlinear pharmacokinetics
Pharmacokinetics Chapter 4.
Inhibited Enzyme Kinetics Inhibitors may bind to enzyme and reduce their activity. Enzyme inhibition may be reversible or irreversible. For reversible.
Enzyme activity is measured by the amount of product produced or the amount of substrate consumed. The rate of the enzymatic reaction is measured by the.
Practical Pharmacokinetics
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Pharmacokinetics: Asmah Nasser, M.D..
Drug Disposition Porofessor Hanan hager Dr.Abdul latif Mahesar College of medicine King Saud University.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
LONGITUDNAL SECTION OF KIDNEY KLECOP, Nipani.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
University of Jordan-Faculty of Pharmacy
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Nonlinear Pharmacokinetics
Nonlinear Pharmacokinetics Prepared By, Jahanvi H. Patel Roll No:09MPH103 Dept: Pharmaceutical Technology & Biopharmaceutics Guided By: Dhaivat C. Parikh.
Pharmacokinetics Introduction
Non-linear Pharmacokinetics Arthur G. Roberts. Linear Pharmacokinetics AUC dose K Cl dose [Drug] plasma time ln[Drug] plasma time Increasing Dose.
1 Applied Pharmacokinetics of Antiepileptic Drugs (AEDs) B. Gitanjali Gitanjali-21:
Bioavailability Dr Mohammad Issa.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Pharmacology Department
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
PHARMACOKINETICS Part 3.
NON LINEAR PHARMACOKINETICS Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas 2013.
Errata Lecture 10 Slide 18 Rational because However.
Plasma Protein Binding
BASIC BIOPHARMACEUTICS
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
BIOPHARMACEUTICS.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
MS Phoenix WinNonLin Project
Nonlinear Pharmacokinetics
Clarifications of Lecture #36- Drug Interactions I
DRUG INTERACTIONS I Lecture #36. Drug Interactions Terms Therapeutic Drug Interaction ADR Additive Synergism.
Clinical Pharmacokinetics of PHENYTOIN & OTHER ANTIEPILEPTICS
Pharmacokinetics 2 General Pharmacology M212
CHAPTER 4 L. VanValkenburg, RVT, BAS Pharmacokinetics.
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
Basic Principles: PK By: Alaina Darby.
Drug therapy in pediatric
Excretion of drugs.
Pharmacology I BMS 242 Lecture II (Continued)
Toxicology Drug Poisioning.
Understanding the Basics of Pharmacology
Pharmacology I BMS 242 Lecture II (Continued)
Pharmacokinetics.
Toxicology Drug Poisioning.
Pharmacokinetics & Drug Dosing
INTRODUCTION to Pharmacology
Clinical Pharmacokinetics
Hawler Medical University
Clinical Pharmacokinetics
Biopharmaceutics Chapter-6
Therapeutic Drug Monitoring chapter 1 part 1
Introduction to Pharmacology
CHAPTER 4 l. VanValkenburg, RVT, BAS
Biopharmaceutics and pharmacokinetic by: Anjam Hama A. M. Sc
BIOAVAILABILITY.
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
Medication Administration for Pediatrics
Presentation transcript:

Grading Average = 91

Errata

Michaelis-Menten Derivation KmKm k cat Formation of ES complex is rapid (k cat <<k off ), therefore Rate Limiting

Michaelis-Menten Derivation KmKm k cat Formation of ES complex is rapid (k cat <<k off ), therefore Rate Limiting

Clarifications

Michaelis-Menten Assumptions Quasi-steady-state approximation – [ES] remains constant at saturating [S] – d[ES]/dt=0 (i.e. forward rate = reverse rate) [E]<<K m and [S] Rapid Equilibrium for the ES complex k cat << k off Product formation is irreversible KmKm k cat k on k off

20% Decrease in Dose (250 mg/day  200 mg/day) 50% decrease anti-seizure (a.k.a. Dilantin) Capacity-Limited Metabolism Excitatory Synapse

NON-LINEARITIES CONTINUED Lecture #35

Review Constant Rate Input IV Bolus Constant Rate Input

Review: Reasons Individualization – Pain – Low Therapeutic Index – Anesthesia Drug Solubility Rapid Degradation/Elimination  High Enough [Drug] plasma Maintain/Control Response Drug Toxicity  Control plasma levels

Review: Time to Reach Plateau 90% of the plateau value

Constant Rate Infusion t 90

Constant Rate Infusion: Plateau R o = constant rate input (mg/hr) KmKm VmVm Cu SS Higher K m (weaker)ConstantHigher Lower K m (tighter)ConstantLower ConstantHigher V m (inducing)Lower ConstantLower V m (inhibiting)Higher What does the extraction ratio have to be?

Constant Rate Infusion: Time to Plateau R o = constant rate input (mg/hr) Km’Km’ VmVm t 90 Higher K m (weaker)Constantlonger Lower K m (tighter)Constantshorter ConstantHigher V m (inducing)shorter ConstantLower V m (inhibiting)longer Basically, it has this correlation.

Concentration-Dependent Renal Excretion

penicillin antibiotic

Concentration-Dependent Renal Excretion A = GFR Only B = GFR and Active Secretion C = GFR and Active Reabsorption

GFR and Active Reabsorption

Saturable Binding to Plasma Proteins n = number of binding sites P t = protein concentration n*P t = concentration of drug binding sites KDKD Cu + Assumptions?

Non-linear binding to  1 -acid glycoprotein  1 -acid glycoprotein Na + channel inhibitor

Saturable Albumin Binding NSAID

Saturable Albumin Binding Binding to Albumin Cephalosporin Antibiotic

Saturable Plasma Protein Binding ACE Inhibitor Prodrug Trandolaprilat Active

Saturable Transport T m = maximum transport rate active or passive transport? Cu in Cu out KTKT

Saturable Tissue Binding endothelin receptor antagonist (ERA) Endothelin-1 ECE = Endothelin Converting Enzyme

Time-Dependent PK (Chronopharmacokinetics) Enzyme Induction Circadian variations – Renal Function, Urine pH,  1 -acid glycoprotein GI Physiology (Food and Drink) – Gastric emptying slowed/delayed by food Autoinduction Mechanism-based Autoinhibition

Chronopharmacokinetics: Renal Function aminoglycoside

Saturable Tissue Binding imirestat aldose reductase inhibitor glaucoma

Saturable Tissue Binding nucleoside transporter inhibitor

Chronopharmacokinetics: Food VDCC =Voltage-dependent Calcium Channel Verapamil Taken At Different Times of the Day

Chronopharmacokinetics: Mechanism- Based Autoinhibition

Chronopharmacokinetics: Autoinduction Excitatory Synapse anticonvulsant

Recognition of Non-linearities Compare with Linear Kinetics Identify altered Kinetic parameters Determine Primary PK parameters (e.g. k, V) Consistent with Mechanism

Assessment of Non-linearities Urine Recovery Concentration-Time Profile Protein Binding

Assessment of Non-linearities Salicylic Acid For Skin

Urine Recovery If Linear If Non-Linear

Concentration-Time Profile If Linear If Non-linear

Protein Binding If linear If Non-linear

Constant Rate Infusion

PK of a Drug Overdose CL T and V often changed t 1/2 increased – e.g. Ethchlorvynol 25 hrs  100 hrs Plasma rebound after dialysis – redistribution in fat (poorly perfused) hypnotic, euphoria insomnia

PK of a Drug Overdose Sedative/Hypnotic If Linear If Non-Linear * Plasma rebound due to redistribution. * schedule IV (USA) controlled cerebral depression mechanism of action is not known.

Therapeutic Consequences of Non- linearities Dose Dependence – Capacity-Limited Metabolism (Major) low E – Dissolution-Limited  Bioavailability – GI physiology  Bioavailability Chronopharmacokinetics – Autoinduction – Mechanism-based Inhibition